Clinical Trial Update: The Bioequivalence Study of Lamotrigine Dispersible/Chewable Tablets 5mg×5 Compared With Lamotrigine Compressed Tablet 25mg in Chinese Healthy Male Subjects [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study comparing lamotrigine dispersible/chewable 5mg×5 with lamotrigine 25mg tablet in healthy Chinese male subjects to assess similar ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Lamotrigine 25mg tablet (compressed) (lamotrigine)
• Lamotrigine dispersible/chewable 5mg×5 (lamotrigine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Epilepsy | Phase 1 | Status: COMPLETED